832735-60-1

Usage

Uses

Used in Medicinal Chemistry:
7-Bromo[1,2,4]triazolo[4,3-a]pyridine is utilized as a key intermediate in the synthesis of novel pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Drug Discovery:
7-Bromo[1,2,4]triazolo[4,3-a]pyridine serves as a valuable building block in organic synthesis, contributing to the creation of innovative molecules with potential medicinal properties. Its presence in synthesized compounds may enhance their efficacy and selectivity in targeting specific biological pathways.
Used in Scientific Research:
7-Bromo[1,2,4]triazolo[4,3-a]pyridine's potential biological activities make it an intriguing subject for further research and development across various scientific disciplines. Its exploration may lead to the discovery of new mechanisms of action and applications in different fields.

InChI:InChI=1/C6H4BrN3/c7-5-1-2-10-4-8-9-6(10)3-5/h1-4H

Upstream product

• 64-18-6 formic acid 
• 1019918-39-8 4-bromo-2-hydrazineylpyridine 
• 128071-98-7 4-bromo-2-fluoropyridine 

Downstream Products

• 1379186-04-5 [1,2,4]triazolo[4,3-a]pyridin-7-amine 

Relevant academic research and scientific papers

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS AND COMBINATIONS THEREOF

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.

CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1

This invention relates to novel compounds of the Formula Formulas (I), (Ia1-20), (Ib1-20), (Ic1-20), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11β-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of cortisol in a cell or the inhibition of the conversion of cortisone to cortisol in a cell.